Latest & greatest articles for dementia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dementia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on dementia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for dementia

1. Person-centred care improves quality of life for care home residents with dementia

Person-centred care improves quality of life for care home residents with dementia Signal - Person-centred care improves quality of life for care home residents with dementia Dissemination Centre Discover Portal NIHR DC Discover Person-centred care improves quality of life for care home residents with dementia Published on 20 March 2018 A person-centred care intervention for people with dementia living in care homes improved their quality of life, reduced agitation and improved interactions (...) use, as this was low to start with, which is in line with policy to limit use. It supports the feasibility of the intervention, but there is a need to understand which components are most effective and could be implemented on a wide scale with sustainable effects. Share your views on the research. Why was this study needed? Over 400,000 older people currently live in care homes in the UK. This includes over a third of the UK population with dementia. Many people with dementia have complex care

NIHR Dissemination Centre2019

2. Case managers improve outcomes for people with dementia and their carers

Case managers improve outcomes for people with dementia and their carers Case managers improve outcomes for people with dementia and their carers Dissemination Centre Discover Portal NIHR DC Discover Case managers improve outcomes for people with dementia and their carers Published on 24 April 2018 Using a case manager to coordinate health and social care improves the challenging behaviour of people with dementia and reduces the burden on caregivers. Quality of life of caregivers improves (...) the most when case managers have a professional background in nursing. This NIHR-funded review compared the effectiveness of standard community treatment and interventions with case managers overseeing the interventions for people living with dementia. It considered evidence from 14 trials in a number of countries, with different health systems and support. Care coordination is variable across the UK, but this is often not provided by a qualified professional, so they are not able to develop and update

NIHR Dissemination Centre2019

3. Coordinating care for people with long term conditions and dementia: room for improvement

Coordinating care for people with long term conditions and dementia: room for improvement Signal - Coordinating care for people with long term conditions and dementia: room for improvement Dissemination Centre Discover Portal NIHR DC Discover Coordinating care for people with long term conditions and dementia: room for improvement Published on 26 May 2016 New evidence shows that almost one fifth of people with dementia also have other serious conditions such as stroke, diabetes and visual (...) impairment. Services are not currently designed to provide adequate integrated care for people with dementia plus other conditions. For instance, people with dementia are less likely to get diabetes checks or cataract surgery than those without dementia. Carers are not routinely contacted, and there is a lack of guidance for health professionals covering more than one condition. Implications for practice include incorporating the impact of a diagnosis of dementia on pre-existing conditions into care

NIHR Dissemination Centre2019

4. A third of people with dementia have treatable vision problems

A third of people with dementia have treatable vision problems Signal - A third of people with dementia have treatable vision problems Dissemination Centre Discover Portal NIHR DC Discover A third of people with dementia have treatable vision problems Published on 27 September 2016 New data shows that around a third of people with dementia have serious vision problems, such as cataracts or short sightedness, more than the general population of that age. Levels are higher still for people (...) with dementia in care homes – about half have vision problems. Yet this study showed that many of the people with dementia and vision impairment had not received the right treatment. This often involves simple measures. For many, spectacles could have improved poor sight. A quarter had cataracts, which surgery could have corrected. Quality of life is known to improve if visual impairment is corrected. Failure to receive treatment may be due to lack of awareness amongst people with dementia and their carers

NIHR Dissemination Centre2019

5. Antidepressants do not help treat depression in people living with dementia

Antidepressants do not help treat depression in people living with dementia Antidepressants do not help treat depression in dementia Dissemination Centre Discover Portal NIHR DC Discover Antidepressants do not help treat depression in people living with dementia Published on 8 January 2019 doi: Antidepressants do not reduce symptoms of depression in people with dementia compared with placebo (dummy pills). Measured 6 to 13 weeks after starting the treatment, there is little or no difference (...) in participants’ symptoms, but an increased chance of unwanted side effects. The review did not identify enough data to determine if antidepressants have an effect in the longer-term. This Cochrane review included randomised controlled trials of any antidepressant drugs compared to placebo. Participants were aged 75 years on average, with mild or moderate dementia. The quality of the included trials was mixed, with not enough information reported to fully assess the risk of bias, though the main result

NIHR Dissemination Centre2019

6. A staff training intervention to improve communication between people living with dementia and health-care professionals in hospital: the VOICE mixed-methods development and evaluation study

A staff training intervention to improve communication between people living with dementia and health-care professionals in hospital: the VOICE mixed-methods development and evaluation study A staff training intervention to improve communication between people living with dementia and health-care professionals in hospital: the VOICE mixed-methods development and evaluation study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page (...) not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} VOICE communication training for health-care professionals working with people with dementia is likely to be beneficial to staff and patients, but further evaluation is necessary. {{author}} {{($index , , , , , , , , , , , & . Rowan

NIHR HTA programme2019

7. National clinical guideline for diagnosis of mild cognitive impairment and dementia

National clinical guideline for diagnosis of mild cognitive impairment and dementia National clinical guideline for diagnosis of mild cognitive impairment and dementia Published by the Danish Health Authority, October 2018 NATIONAL CLINICAL GUIDELINE FOR DIAGNOSIS OF MILD COGNITIVE IMPAIRMENT AND DEMENTIA Quick guide Use a brief cognitive test as part of a basic clinical assessment of MCI or dementia in order to achieve a systematic, structured assessment of the level of cognitive functioning (...) . Strong recommendation A brief cognitive test cannot stand alone, and the results should always be understood in the light of other test results and the overall clinical context. Despite certain methodological weaknesses as regards the evidence base, the results indicate that a brief cognitive test contributes relevant information in the assessment of dementia and MCI. There is no documentation that a brief cognitive test alone can contribute significantly towards predicting which persons with MCI

Danish National Clinical Guidelines2019

8. France has delisted anti-dementia agents

France has delisted anti-dementia agents MED CHECK - TIP December 2018/ Vol.4 No.12 · Page 29 -The Informed Prescriber C N o 12 M ED HECK D e ce m b e r 2 0 1 8 Dying Cochrane: Could it be resuscitated? Herpes zoster subunit vaccine Shingrix: Baloxavir (Xofluza®) for Influenza: No Value No difference from Tamiflu in efficacy, and suppresses immunity Cochrane review on HPV vaccine should be revised: Due to missing trials, adjuvant toxicity, mortality and healthy user bias Editorial Dying

Med Check - The Informed Prescriber2019

9. Traditional Chinese herbal medicine for vascular dementia.

Traditional Chinese herbal medicine for vascular dementia. BACKGROUND: Traditional Chinese herbal medicine (TCHM) is widely used for treating vascular dementia (VaD) in China. Recent studies of a number of TCHMs have demonstrated in vitro biological activity and therapeutic effects in animals, but the published clinical evidence has not been systematically appraised. OBJECTIVES: To evaluate the efficacy and safety of TCHMs listed in either the Chinese Pharmacopoeia (CP) or the Chinese National (...) Essential Drug List (NEDL) that are used to treat VaD. A secondary aim was to identify promising TCHMs for further clinical research. SEARCH METHODS: We searched ALOIS, the Cochrane Dementia and Cognitive Improvement Group's Specialised Register (on 14 March 2018) and also several Chinese biomedical databases: the Chinese Biological Medicine Database (January 1979 to May 2015), Wanfang database (January 1998 to May 2015), Chongqing VIP Information Co. Ltd or Weipu (January 1998 to May 2015

Cochrane2018

10. Accuracy of Dementia Screening Instruments in Emergency Medicine: A Diagnostic Meta-analysis

Accuracy of Dementia Screening Instruments in Emergency Medicine: A Diagnostic Meta-analysis 30222232 2018 11 08 1553-2712 2018 Sep 17 Academic emergency medicine : official journal of the Society for Academic Emergency Medicine Acad Emerg Med Accuracy of Dementia Screening Instruments in Emergency Medicine: A Diagnostic Meta-analysis. 10.1111/acem.13573 Dementia is underrecognized in older adult emergency department (ED) patients, which threatens operational efficiency, diagnostic accuracy (...) , and patient satisfaction. The Society for Academic Emergency Medicine geriatric ED guidelines advocate dementia screening using validated instruments. The objective was to perform a systematic review and meta-analysis of the diagnostic accuracy of sufficiently brief screening instruments for dementia in geriatric ED patients. A secondary objective was to define an evidence-based pretest probability of dementia based on published research and then estimate disease thresholds at which dementia screening

EvidenceUpdates2018

11. Cognition and Vitamin D in Older African-American Women- Physical performance and Osteoporosis prevention with vitamin D in older African Americans Trial and Dementia

Cognition and Vitamin D in Older African-American Women- Physical performance and Osteoporosis prevention with vitamin D in older African Americans Trial and Dementia 30359476 2018 10 25 1532-5415 2018 Oct 25 Journal of the American Geriatrics Society J Am Geriatr Soc Cognition and Vitamin D in Older African-American Women- Physical performance and Osteoporosis prevention with vitamin D in older African Americans Trial and Dementia. 10.1111/jgs.15607 To examine the effect of 25-hydroxyvitamin D (...) cognition dementia vitamin D 2018 04 16 2018 08 01 2018 08 20 2018 10 26 6 0 2018 10 26 6 0 2018 10 26 6 0 aheadofprint 30359476 10.1111/jgs.15607

EvidenceUpdates2018

12. A manual-based intervention for carers of people with dementia and sleep disturbances: an acceptability and feasibility RCT

A manual-based intervention for carers of people with dementia and sleep disturbances: an acceptability and feasibility RCT A manual-based intervention for carers of people with dementia and sleep disturbances: an acceptability and feasibility RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above (...) to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} This study designed an intervention to help dementia carers manage their relatives' sleep disturbances and showed that it would be acceptable and feasible to evaluate in a full randomised trial. {{author}} {{($index , , , , , , , , , , & . Kirsi M Kinnunen 1 , Penny Rapaport 1 , Lucy Webster 1 , Julie Barber 2 , Simon D Kyle 3 , Brendan Hallam 1 , Claudia Cooper 1, 4

NIHR HTA programme2018

13. Dementia caregiver interventions in Chinese people: A systematic review

Dementia caregiver interventions in Chinese people: A systematic review 30264464 2018 11 13 1365-2648 2018 Sep 27 Journal of advanced nursing J Adv Nurs Dementia caregiver interventions in Chinese people: A systematic review. 10.1111/jan.13865 The aim of this systematic review was to examine the characteristics and the efficacy of dementia caregiving interventions among the Chinese population. In recent years, an increasing number of dementia caregiving interventions have been developed (...) . Although the review found mixed results on intervention outcomes, the majority of interventions showed a potential to improve the health and well-being of dementia caregivers and care recipients. This review provides suggestions for future dementia caregiving research in the Chinese population, such as inclusion of relevant theoretical frameworks and more rigorous research designs. © 2018 John Wiley & Sons Ltd. Wu Bei B http://orcid.org/0000-0002-6891-244X New York University Rory Meyers College

EvidenceUpdates2018

14. Agitation in Dementia: Quantifying the effects of antipsychotics

Agitation in Dementia: Quantifying the effects of antipsychotics Tools for Practice is proudly sponsored by the Alberta College of Family Physicians (ACFP). ACFP is a provincial, professional voluntary organization, representing more than 4,800 family physicians, family medicine residents, and medical students in Alberta. Established over sixty years ago, the ACFP strives for excellence in family practice through advocacy, continuing medical education and primary care research. www.acfp.ca (...) February 26, 2018 Agitation in Dementia: Quantifying the effects of antipsychotics Clinical Question: What are the benefits and harms of antipsychotics for agitation in dementia? Bottom Line: A strong placebo effect explains most of the perceived efficacy, with antipsychotics providing little additional improvement over placebo on agitation scales (~3 additional points out of 144). However, 50% improvement in behaviour occurs in ~46% on antipsychotic versus ~33% on placebo. Harms are serious (increased

Tools for Practice2018

15. A protocol to evaluate the impact of involvement of older people with dementia and age-related hearing and/or vision impairment in a multi-site European research study

A protocol to evaluate the impact of involvement of older people with dementia and age-related hearing and/or vision impairment in a multi-site European research study 30498579 2018 12 03 2056-7529 4 2018 Research involvement and engagement Res Involv Engagem A protocol to evaluate the impact of involvement of older people with dementia and age-related hearing and/or vision impairment in a multi-site European research study. 44 10.1186/s40900-018-0128-9 Involving older people with dementia (...) in research is increasingly recognised as important to ensure that research is relevant and beneficial for older people with dementia. But researchers need to know how best to involve older people with dementia and to be able to show the benefits of involving older people with dementia in dementia research.This paper describes a research plan to explore the involvement of older people with dementia and age-related hearing and/or vision impairment in a European research project investigating the combined

Research involvement and engagement2018 Full Text: Link to full Text with Trip Pro

16. Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment.

Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment. BACKGROUND: Vitamins and minerals have many functions in the nervous system which are important for brain health. It has been suggested that various different vitamin and mineral supplements might be useful in maintaining cognitive function and delaying the onset of dementia. In this review, we sought to examine the evidence for this in people who already had mild (...) cognitive impairment (MCI). OBJECTIVES: To evaluate the effects of vitamin and mineral supplementation on cognitive function and the incidence of dementia in people with mild cognitive impairment. SEARCH METHODS: We searched ALOIS, the Cochrane Dementia and Cognitive Improvement Group's (CDCIG) specialised register, as well as MEDLINE, Embase, PsycINFO, CENTRAL, CINAHL, LILACs, Web of Science Core Collection, ClinicalTrials.gov, and the WHO Portal/ICTRP, from inception to 25 January 2018. SELECTION

Cochrane2018

17. Pre-eclampsia and risk of dementia later in life: nationwide cohort study.

Pre-eclampsia and risk of dementia later in life: nationwide cohort study. OBJECTIVE: To explore associations between pre-eclampsia and later dementia, overall and by dementia subtype and timing of onset. DESIGN: Nationwide register based cohort study. SETTING: Denmark. POPULATION: All women with at least one live birth or stillbirth between 1978 and 2015. MAIN OUTCOME MEASURE: Hazard ratios comparing dementia rates among women with and without a history of pre-eclampsia, estimated using Cox (...) regression. RESULTS: The cohort consisted of 1 178 005 women with 20 352 695 person years of follow-up. Women with a history of pre-eclampsia had more than three times the risk of vascular dementia (hazard ratio 3.46, 95% confidence interval 1.97 to 6.10) later in life, compared with women with no history of pre-eclampsia. The association with vascular dementia seemed to be stronger for late onset disease (hazard ratio 6.53, 2.82 to 15.1) than for early onset disease (2.32, 1.06 to 5.06) (P=0.08

BMJ2018 Full Text: Link to full Text with Trip Pro

18. Valproate preparations for agitation in dementia.

Valproate preparations for agitation in dementia. BACKGROUND: Agitation has been reported in up to 90% of people with dementia. Agitation in people with dementia worsens carer burden, increases the risk of injury, and adds to the need for institutionalisation. Valproate preparations have been used in an attempt to control agitation in dementia, but their safety and efficacy have been questioned. OBJECTIVES: To determine the efficacy and adverse effects of valproate preparations used to treat (...) agitation in people with dementia, including the impact on carers. SEARCH METHODS: We searched ALOIS - the Cochrane Dementia and Cognitive Improvement Group's Specialized Register on 7 December 2017 using the terms: valproic OR valproate OR divalproex. ALOIS contains records from all major health care databases (the Cochrane Library, MEDLINE, Embase, PsycINFO, CINAHL, LILACS) as well as from many trials databases and grey literature sources. SELECTION CRITERIA: Randomised, placebo-controlled trials

Cochrane2018

19. Cumulative Antidepressant Use and Risk of Dementia in a Prospective Cohort Study

Cumulative Antidepressant Use and Risk of Dementia in a Prospective Cohort Study 30221747 2018 10 11 1532-5415 66 10 2018 Oct Journal of the American Geriatrics Society J Am Geriatr Soc Cumulative Antidepressant Use and Risk of Dementia in a Prospective Cohort Study. 1948-1955 10.1111/jgs.15508 To determine whether antidepressant use is associated with dementia risk. Prospective cohort study. Kaiser Permanente Washington (KPWA), an integrated healthcare delivery system. Community-dwelling (...) individuals aged 65 and older without dementia and with 10 years or more of KPWA enrollment at baseline (N=3,059). Primary exposures were selective serotonin reuptake inhibitors (paroxetine vs other), tricyclic antidepressants, and serotonin antagonist and reuptake inhibitors. Using health plan pharmacy data, we calculated cumulative medication exposure, defined as total standardized daily doses (TSDDs), over rolling 10-year windows. Exposure in the most recent year was excluded to avoid use related

EvidenceUpdates2018

20. Modifying the consistency of food and fluids for swallowing difficulties in dementia.

Modifying the consistency of food and fluids for swallowing difficulties in dementia. BACKGROUND: People with dementia can have feeding and swallowing difficulties (dysphagia). Modification of the consistency of food or fluids, or both, is a common management strategy. However, diet modification can affect quality of life and may lead to dehydration and malnutrition. Evidence on the benefits and risks of modifying food and fluids is mandatory to improve the care of people with dementia (...) and dysphagia. OBJECTIVES: To determine the effectiveness and adverse effects associated with modifying the consistency of food and fluids in improving oral intake and eliminating aspiration in adults with dysphagia and dementia. SEARCH METHODS: We searched ALOIS (the Specialised Register of the Cochrane Dementia and Cognitive Improvement Group), the Cochrane Library, MEDLINE via Ovid SP, Embase via Ovid SP, PsycINFO via Ovid SP, CINAHL via EBSCOhost, LILACS via BIREME, ClinicalTrials.gov and the World

Cochrane2018